Abbott Reports Second-Quarter 2022 Results and Raises Full-Year EPS Guidance Pharmaceutical Investing
Bloom Health Partners Announces Closing of Second Tranche of Private Placement for over C$1.58M in Aggregate Gross Proceeds Medical Device Investing
Johnson & Johnson's Executive Vice President, General Counsel Michael Ullmann to Retire; Elizabeth Forminard Named General Counsel, Effective October 17, 2022 Pharmaceutical Investing
Medtronic expands Health Equity Assistance Program for colon cancer screening with support from Amazon Web Services; Completes first installation of donated GI Genius intelligent endoscopy modules Medical Device Investing
Medtronic receives FDA clearance for next-generation UNiD Spine Analyzer with degenerative spine surgery predictive model Medical Device Investing
Abbott Receives FDA's Breakthrough Device Designation to Explore Use of Deep Brain Stimulation to Manage Severe Depression Pharmaceutical Investing
Medtronic announces co-promotion agreement with CathWorks, with path toward acquisition Medical Device Investing